ARTICLE | Clinical News
Herceptin trastuzumab regulatory update
October 16, 2006 7:00 AM UTC
ROCZ submitted an MAA to EMEA for Herceptin to treat advanced HER2-positive and hormone receptor-positive breast cancer. The humanized monoclonal antibody against epidermal growth factor (EGF) recept...